Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial

DSpace Repository

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial

Author: Flaadt, Tim; Ladenstein, Ruth L.; Ebinger, Martin; Lode, Holger N.; Arnardottir, Helga Bjoerk; Poetschger, Ulrike; Schwinger, Wolfgang; Meisel, Roland; Schuster, Friedhelm R.; Doering, Michaela; Ambros, Peter F.; Queudeville, Manon; Fuchs, Joerg; Warmann, Steven W.; Schaefer, Juergen; Seitz, Christian; Schlegel, Patrick; Brecht, Ines B.; Holzer, Ursula; Feuchtinger, Tobias; Simon, Thorsten; Schulte, Johannes H.; Eggert, Angelika; Teltschik, Heiko-Manuel; Illhardt, Toni; Handgretinger, Rupert; Lang, Peter
Tübinger Autor(en):
Flaadt, Tim
Ebinger, Martin
Queudeville, Manon
Seitz, Christian
Brecht, Ines B.
Holzer, Ursula
Illhardt, Toni
Handgretinger, Rupert
Lang, Peter
Döring, Michaela
Fuchs, Jörg
Warmann, Steven
Schäfer, Jürgen Frank
Published in: Journal of Clinical Oncology (2023), Bd. 41, H. 17, S. 3135-3148
Verlagsangabe: Philadelphia : Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1200/JCO.22.01630
ISSN: 0732-183X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)